These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23157520)

  • 21. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical issues in the relationships involving medicine and industry.
    Thomas PS; Tan KS; Yates DH
    Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554
    [No Abstract]   [Full Text] [Related]  

  • 23. Statin, the black box.
    Hatem S; Boccara F
    Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
    [No Abstract]   [Full Text] [Related]  

  • 24. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 25. Myopathy caused by a combination rosuvastatin and fenofibrate.
    Dedhia V; Munsi SC
    J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
    [No Abstract]   [Full Text] [Related]  

  • 26. Rosuvastatin and vitamin D: might there be hypovitaminosis D on JUPITER?
    Goldstein MR; Mascitelli L; Pezzetta F
    Int J Cardiol; 2010 Dec; 145(3):556-7. PubMed ID: 20557956
    [No Abstract]   [Full Text] [Related]  

  • 27. Trust in the medical literature--and Viewpoints in JAMA Internal Medicine.
    Steinbrook R; Redberg RF
    JAMA Intern Med; 2013 Jun; 173(12):1047-8. PubMed ID: 23609117
    [No Abstract]   [Full Text] [Related]  

  • 28. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological aspects of gifts from drug companies.
    Tansey M
    JAMA; 2003 Nov; 290(18):2405-6; author reply 2406-7. PubMed ID: 14612470
    [No Abstract]   [Full Text] [Related]  

  • 31. The Jupiter trial--new territory for statins?
    Wheeler DC
    Nephrol Dial Transplant; 2009 Jul; 24(7):2036-7. PubMed ID: 19541666
    [No Abstract]   [Full Text] [Related]  

  • 32. Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure.
    Mortensen SA
    J Am Coll Cardiol; 2011 Apr; 57(14):1569; author reply 1569. PubMed ID: 21453843
    [No Abstract]   [Full Text] [Related]  

  • 33. [The JUPITER study].
    Gaspardone A; Maseri A
    G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
    [No Abstract]   [Full Text] [Related]  

  • 34. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
    Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
    [No Abstract]   [Full Text] [Related]  

  • 35. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?
    Rizzo M; Berneis K; Spinas GA; Rini GB; Kapur NK
    Int J Clin Pract; 2009 Mar; 63(3):478-85. PubMed ID: 19222633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Industry and the academy: conflicts of interest in contemporary health research.
    Downie J; Baird P; Thompson J
    Health Law J; 2002; 10():103-22. PubMed ID: 14748274
    [No Abstract]   [Full Text] [Related]  

  • 38. Full disclosure.
    Maxwell D
    Can Fam Physician; 2008 Oct; 54(10):1377-8; discussion 1378. PubMed ID: 18854458
    [No Abstract]   [Full Text] [Related]  

  • 39. Rosuvastatin in patients with elevated C-reactive protein.
    Pierard LA
    N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
    [No Abstract]   [Full Text] [Related]  

  • 40. Complications and side effects. Crestor tested in PHAs.
    TreatmentUpdate; 2005; 17(4):6-7. PubMed ID: 17230630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.